Govt Set to Roll Out Stricter Norms for Biosimilar Approvals

The Indian government is putting final touches on revised regulations to tighten quality requirements for biosimilar medicines, treatments derived from living cells applied in the treatment of cancers and...

Senores Pharma Acquires FDA-Approved Topiramate ANDA from Wockhardt

Topiramate hydrochloride tablets from Wockhard Ltd have been approved by Abbreviated New Drug Application, the achievement of the US FDA, announced by Ahmedabad-based Senores Pharmaceuticals Limited.

Akum's Breakthrough Tablet Brings Relief for Morning Sickness

Akums Drugs & Pharmaceuticals Ltd., a leading Indian pharmaceutical company, just got a patent for a new tablet that’s a game-changer for pregnant women struggling with nausea and vomiting. This exciting invention is here to make pregnancy a littl...

Commission Recommends Ban on In-Hospital Pharma Rep Visits

Pharmaceutical representatives will be prevented from meeting with doctors in person at hospitals, according to the major reform suggested by the Health Sector Reform Commission of Bangladesh...

FDA Grants Fast Track Status to IGI's ISB 2001 for Difficult-to-Treat Multiple Myeloma

IGI, a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ISB 2001.

Mahajan Imaging Launches North Indias First 128 Slice Digital PET CT Scanner

Delhi NCR, May 6th , 2025: Mahajan Imaging & Labs, a pioneer in advanced diagnostics and medical imaging, inaugurated North India’s first 128 Slice Digital PET-CT -Omni Legend by GE HealthCare and state of the art P...

Indian CDMOs Gain Momentum as Global Pharma Diversifies Away from China

Indian Contract Development and Manufacturing Organisations (CDMOs) like Suven Pharmaceuticals, Syngene International, Laurus Labs, and Divi’s Laboratories are witnessing a surge in demand as global pharma players seek to reduce dependence on...

Biocon Biologics Expands U.S. Reach as Yesintek Wins Key Formulary Backing

Biocon Biologics has accomplished a major breakthrough in the U.S. with wide-ranging market access for Yesintek (ustekinumab-kfce), its biosimilar to Stelara, marking its first commercial launch in the country as a fully combined biosimilar company.

New Akums Patent Offers Safer Medication Delivery for Expectant Mothers

A leading contract research and manufacturing organization, Akums Drugs & Pharmaceuticals, has established a patent for its novel extended-release invention of doxylamine and pyridoxine.

Clinical Trial Finds Semaglutide Reverses Liver Damage in MASH Patients

The New England Journal of Medicine recently published a study of semaglutide. This trail was conducted across 37 countries over 253 sites.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.